Pomerantz LLP has filed a class action lawsuit against Pacira Pharmaceuticals, Inc. (“Pacira” or the “Company”) (Nasdaq:PCRX) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, and docketed under 14-cv-06172, is on behalf of a class consisting of all persons or entities who purchased Pacira securities […]
